Risk for liver-related death far greater in HCV seropositive patients with HIV

  • May 15, 2013

Patients who were hepatitis C virus seropositive and coinfected with HIV had nearly a ninefold increased risk for liver-related death compared with patients who were HCV seronegative with no correlations to HCV viremia level or genotype in a recent study.

In a prospective study, researchers enrolled 13,025 patients (mean age, 37.5 years; 74.2% men) with HIV and known HCV antibody (HCVAb) from the EuroSIDA cohort (1994-2011) that included 18,295 HIV-1 infected patients from 105 centers in Europe, Israel and Argentina. Thirty-one percent of the patients had detectable HCVAb (n=4,044), including 3,745 who were seropositive at baseline and the remainder who initially were HCVAb negative but showed detectable anti-HCV antibodies during follow-up.

Full Story »
  • Filter By:
  • CME

  • HIV Neuropsychiatry

  • In this age of antiretroviral therapy, people with acquired immunodeficiency syndrome (AIDS) now survive long enough to find themselves living with a chronic disease rather than imminently dying from…...More »
  • Breaking News Perspective

  • NIH stops HIV vaccine clinical trial

  • April 26, 2013
  • The National Institute of Allergy and Infectious Diseases, part of the NIH, has discontinued the HVTN 505 clinical trial of an investigational HIV vaccine...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

More »
More »
More »
More »
[X]